Researchers target bat genes in quest for drug to combat Covid-19
- A team from China, Singapore and the US says an inhibitor molecule called carolacton could have pharmaceutical potential
- Gene-blocking compound might be able to stop replication of virus, scientists say
In a research paper published online on Monday, scientists from China, Singapore and the United States said carolacton, which inhibits a specific bat gene, could help suppress the infection of Sars-CoV-2, the coronavirus that causes Covid-19.
The joint paper was published on online archive bioRxiv by researchers from Tsinghua University, the Chinese Centre for Disease Control and Prevention, and the Chinese Academy of Sciences as well as teams from Singapore’s Duke – NUS Medical School and Duke University.
The paper has not been peer reviewed.
The team examined the gene functions of the black fruit bat and found that carolacton inhibited MTHFD1, a key gene in the production of purine, a critical element in viral replication in both bats and people.